Latest Cipla stock price

Cipla P/E Ratio

CIPLA • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
23.61
Moderate Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 23.61
Current Price ₹1314.70
EPS (TTM) ₹65.29
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 25.55
Historical Range 17.15 - 36.79
Percentile 37.5%

Sector Context

Sector Average 49.52
Sector Median 26.63
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹56.30
Sept 2025 ₹16.73
Mar 2025 ₹15.13

Key P/E Ratio Insights for Cipla

  • Trading at discount to sector average PE of 49.52

View the CIPLA equity price for detailed stock performance.

P/E Ratio Historical Trend for Cipla

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 27.16 56.3 ₹1529.10 NSE High
2024 20.25 61.79 ₹1251.00 NSE Moderate
2023 23.31 45.94 ₹1070.95 NSE Moderate
2022 28.46 32.7 ₹930.50 NSE High
2021 25.96 31.84 ₹826.60 NSE High
2020 17.15 27.75 ₹475.90 NSE Moderate
2019 25.28 20.69 ₹523.05 NSE High
2018 36.79 16.62 ₹611.50 NSE High

Sector P/E Ratio Comparison

Comparing Cipla with other companies in Healthcare sector
Sector Average
49.52
Sector Median
26.63
Lowest P/E
0.97
Highest P/E
993.26
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.97 ₹36 Low
Murae Organisor MURAE 3.0 ₹43 Low
Ind Swift Laboratories INDSWFTLAB 4.67 ₹1,166 Low
Medicamen Organics MEDIORG 6.33 ₹26 Low
Amwill Health Care AMWILL 6.53 ₹70 Low
Galaxy Medicare GML 7.25 ₹24 Low
Unichem Laboratories UNICHEMLAB 7.74 ₹2,188 Low
Zenith Drugs ZENITHDRUG 7.9 ₹76 Low
Brooks Laboratories BROOKS 8.01 ₹184 Low
Vasundhara Rasayans VRL 9.97 ₹37 Low